2 hrs ago
Volt Information Sciences to List on the Nyse MKT Exchange
'We are extremely pleased to be listed on the NYSE MKT after more than three years of trading on the OTC,' stated , President and Chief Executive Officer of Volt.
Volt Information Sciences Reports Operating Income in the Second Quarter
Volt Information Sciences, Inc. today reported financial results for its fiscal second quarter ended May 4, 2014.
Press release distribution, EDGAR filing, XBRL, regulatory filings
The company reported a net loss in the second... Fibrocell Science Receives Orphan Drug Designation for Genetically-Modified Autologous Human Fibroblasts to Advance Treatment Development for Recessive Dystrophic Epidermolysis Bullosa )--Fibrocell Science, Inc., , an autologous cell therapy company primarily focused on developing first-in-class ... (more)
Volt Information Sciences to Host Second Quarter Fiscal Year 2014 Earnings Conference Call June 13th
Ron Kochman, President and Chief Executive Officer, and James Whitney, Senior Vice President and Chief Financial Officer, will discuss the quarter's results and accomplishments.